The subcellular distribution of the c2-adrenergic receptor, pertussis-toxin substrates (Gi, the inhibitory Gprotein) and adenylate cyclase was determined in human platelets. The a2-adrenergic receptor and pertussistoxin substrate activity codistribute with surface membranes identified by a novel fluorescent-lectin method.
INTRODUCTION
Regulation of many cellular functions by drugs and hormones involves membrane receptors and guaninenucleotide-binding proteins (G-proteins) (see ref. [1] for review). In addition to mediating stimulation and inhibition of adenylate cyclase, other effector responses have been shown to be mediated by G-proteins, including stimulation of phospholipases A2 and C [2] [3] [4] and regulation of ion channels [5] .
It has been proposed that the a subunit of G-proteins can be released from the plasma membrane upon receptor activation [6] . Experimental support for the existence of soluble a subunit is well established for the rhodopsintransducin system [7] . Similar suggestions have been made for G-proteins in neutrophils [8] , liver membranes [9] , S49 lymphoma-cell membranes [10] and human platelets [11, 12] . The movement of G-protein a subunits to intracellular locations other than the plasma membrane has significant implications for the types of processes that can be activated by those transducing proteins. Specifically, cytosolic or secretory granule mechanisms could be activated. Conversely, loss of c subunits from the plasma membrane would result in uncoupling of receptors from their plasma membrane responses. Many reports of such soluble G-protein subunits are only qualitative, and do not give a reliable estimate of the fraction of the G-protein that is soluble. A quantitative account of the distribution of G-protein subunits is necessary to place in perspective the hypotheses based on the presence of soluble ac subunits.
Human blood platelets have been a useful system for studies of the mechanism of the Gi-mediated adenylate cyclase inhibition induced by a2-adrenergic agonists [13] [14] [15] . Both ligand binding to G-protein-linked receptors and functional desensitization may depend on the relative distribution of the receptor and its transducing G-protein. Agonist binding to a2-adrenergic receptors in platelet membranes is characterized by two affinity states [15] [16] [17] . The high-affinity a2-agonist binding requires a pertussis-toxin-sensitive G-protein [18, 19] and appears to represent the functional form of the a2 receptor [20] . In addition to the high-affinity binding, a2 agonists bind approx. 30-4000 of the platelet a2 receptors with low affinity. These 'low-affinity' receptors appear to be unable to couple to-Gi, either because the receptor itself is heterogeneous or because compartmentation of the receptor or Gi prevents them from interacting with each other [15, 21] . Indeed, desensitization of the ,-adrenergic receptor is accompanied by sequestration of the receptor in a membrane compartment that is devoid of functional Gs [22, 23] .
We report here determination of the pertussis-toxin substrate (G1) in various subcellular fractions of the human platelet and compare its distribution with that of the ac2-adrenergic receptor and adenylate cyclase. Three questions are addressed: (1) what is the quantitative amount of Gi in the soluble fraction and in the various membrane fractions? (2) Collection and preparation of platelets Human platelet concentrates were purchased from the Detroit Chapter of the American Red Cross within 36 h of collection ('stored platelets'). Platelets were isolated essentially as described by Neubig & Szamraj [24] , except that 0.25 M-sorbitol was used instead of sucrose in the freezing and homogenization buffer to permit lectin labelling. In some experiments platelets from freshly drawn blood were used and were prepared as follows. Blood from normal aspirin-free donors was collected by venous puncture after an overnight fast. Processing followed immediately at room temperature. The blood was mixed with I vol. of ACD anticoagulant (0.80 citric acid,H20, 2.20 trisodium citrate,2H20, 2.45 0 dextrose) and centrifuged at 280 gmax for 7 min. Platelet-rich plasma (PRP) was collected and its pH adjusted to 6.50 with ACD to inhibit aggregation. Platelets were pelleted from the PRP by centrifugation at 420 gmax. for 15 min and then resuspended in an equal volume ofTris-buffered saline (20 mM-Tris/HCl, 150 mM-NaCl, 1 mmNa2EDTA, pH 7.6). The platelets were pelleted as above and resuspended in buffer containing 10 PRP was prepared from freshly drawn blood as described above. Aspirin (100,M) was added and the mixture incubated at room temperature for 10 min to prevent subsequent aggregation. The aspirin-treated platelets were then divided into two parts. To one half 100 /SM-(-)-adrenaline (+ )-bitartrate and 0.00500 sodium ascorbate was added, and to the other half 0.0050 sodium ascorbate alone was added. These mixtures were incubated for 3 h at room temperature, at which time the pH was adjusted to 6.50 with ACD, followed by processing as described above. Homogenization and subcellular fractionation of platelets Immediately after thawing the platelets in a water bath at 23°C, 100 ,IM-phenylmethanesulphonyl fluoride was added from a 100 mm stock in ethanol. Platelets were homogenized in 3.5 ml portions (each representing approx. 1.5 unit of platelet concentrate or the platelets obtained from 200 ml of fresh blood) for 8 min in a 'zero-clearance' homogenizer (Kontes no. 866030-023) with a Talboys model 106 motor set at 3000 (-250 rev./min). Homogenization was performed on ice in a cold-room, and was done for a constant period of time rather than a constant number of strokes, as the former was found to yield more consistent results. Under these conditions, 70-950 of the total lactate dehydrogenase was found in soluble fractions (results not shown). Except where noted, the homogenate was then centrifuged at 1200 gmax. for 5 min at 4°C to remove undisrupted and partially disrupted platelets. Samples of the crude homogenate and the low-speed supernatant were diluted 5-fold with 300 (w/w) sorbitol, and the low-speed pellet was resuspended in 1 ml of the same. These samples were included in all assays for the purpose of calculating yields and recoveries. A 2 ml portion of the supernatant from the low-speed spin was layered on 16 ml linear 30-600% sorbitol gradients. The gradients were centrifuged at 130000 gmax.
in a Beckman SW27.1 rotor for 3 h at 4 'C. Fractions were collected from the top of the gradients with an Isco gradient collector by pumping 650 sorbitol in the bottom. This method of collection yielded superior resolution of peaks as compared with collection from the bottom. The fractions were diluted 10-fold with a buffer containing 50 mM-Tris/HCI and I mM-EGTA, pH 7.6, and then pelleted by centrifugation at 145000gmax. for 30 min at 4 'C, followed by resuspension in 1.0-0.3 ml of the same buffer. When larger quantities of membrane fractions were required, platelets were homogenized in 3 ml portions, followed by fractionation as above on two to four parallel gradients. Fractions were collected as above and pooled on the basis of visually estimated turbudity into the three major particulate fractions (L, M and H; see the Results section).
To quantify soluble G1, platelet homogenates were centrifuged at 48000 g for 20 min, and then the supernatant was removed and centrifuged a second time for 100000 g to eliminate any possible contamination by membranes. Portions of the pellet and high-speed supernatant were assayed for Gi activity as described below.
Partially purified human platelet plasma membranes These were prepared by the method of Neubig & Szamraj [24] .
Purified ;o and fly subunits of bovine brain G proteins These were prepared as described in ref. [19] . Assays All assays were performed within 4 days after homogenization on fractions stored at 4 'C.
oc2-Adrenergic receptor. Binding of the a2-adrenergic antagonist [3H]yohimbine was measured as previously described [15] . Determination [25] as modified [15] . The cholate extracts diluted in Lubrol were quick-frozen in a solid-CO2/ethanol bath and stored at -70 'C before being assayed. Incubation of extracts with pertussis toxin (10 lg/ml) and [32P]NAD' (2 /tM) were carried out as previously described [15] . 32p incorporation into protein was quantified by autoradiography of dried gels followed by scintillation counting of the labelled region for radioactivity or by densitometry of autoradiograms. In some experiments, purified G-protein fly subunits were added to the incubations (see below).
Adenylate cyclase. Adenylate cyclase activity was measured as previously described [15] on pelleted fractions. Assays were performed immediately after fractionation to avoid loss of activity. Where noted, 10 ,tM-forskolin was included in the assay. In experiments assessing latency of the enzyme, the membrane fractions were pretreated with the non-ionic detergent Lubrol PX by incubation on ice in the presence of Lubrol PX for 1 h, followed by 1:1 dilution into the standard assay cocktail.
FITC-lectin. FITC fluorescence of gradient fractions was measured by mixing the samples with an equal volume of 20 SDS, followed by measurement of fluorescence at an excitation wavelength of 485 nm and emission wavelength of 525 nm (slits 5 nm) in a Perkin-Elmer LS-5 spectrofluorimeter. Under these conditions, background fluorescence from fractions prepared from unlabelled platelets was negligible (comprising less than 1 % of the total fluorescence).
Miscellaneous. NADH-dependent cytochrome c reductase (antimycin A-insensitive) was measured as described [26] . Monoamine oxidase was measured as described by Wurtman & Axelrod [27] . Lactate dehydrogenase was assayed with a kit from Sigma Chemical Co.
(340-UV); all fractions were diluted 5-50-fold in 0.1 % Triton X-100 before this assay. Protein was measured as described by Lowry et al. [28] , with bovine serum albumin as the standard. Sorbitol was included in the standard curve where interference was found to be significant. Electron microscopy Membrane fractions were pelleted by centrifugation at 130000 gmax. for 35 min at 4°C, followed by resuspension in a few drops of warm 20% gelatin in phosphatebuffered saline (150 mM-NaCl/10 mM-sodium phosphate, pH 7.0). Thin sections were then prepared by the method described by Day et al. [29] and were examined under either a Philips or Zeiss transmission electron microscope.
Data analysis
Values are means+S.E.M. unless otherwise indicated. Statistical differences between groups were determined by unpaired t tests, with a P value of0.05 being considered a significant difference.
RESULTS

Distribution of ;2-adrenergic receptor-G,-adenylate cyclase system
Sorbitol-density-gradient centrifugation of homogenates of stored platelets yielded three major bands of turbidity on visual inspection. These three bands corresponded to three peaks of [3H]yohimbine binding (a2-adrenergic receptor), termed light (L), medium (M) and heavy (H) on the basis of their sedimentation behaviour (Fig. la) . The relative amounts of [3H]yohimbine binding in L, M and H varied somewhat from experiment to experiment. Fig. l(a) shows that the receptor and G, sediment together on the gradients, but adenylate cyclase activity is virtually absent from the L fraction (see below). The enrichment of the a2-adrenergic receptor and Gi in the L fraction and their co-migration with the FITC-lectin (surface label) suggest that they are confined to the plasma membrane. There was no difference in the sedimentation pattern of protein, a2-adrenergic receptor or G. with or without lectin pretreatment of the platelets (results not shown). Fig. 1(b) shows the distribution of protein, monoamine oxidase and antimycin-A-insensitive NADH-dependent cytochrome c reductase for the same gradient shown in Fig. l(a) . Although not determined for this particular experiment, the cytosolic marker lactate dehydrogenase has the highest activity in fractions 1 or 2 in such gradients and is virtually absent in fractions 5 and above. The markers for mitochondria (monoamine oxidase) and for intracellular membranes (antimycin-A-insensitive NADH-dependent cytochrome c reductase) were most enriched in the peak of intermediate density (M).
The assignment of subcellular fractions was confirmed and the location of platelet a-granules and dense core granules determined by electron microscopy. Electronmicroscopic examination of thin sections of pooled membranes from fractions L, M and H of stored platelets revealed a distinctive ultrastructural appearance in each fraction, similar to that reported for similar fractions by Vol. 265 Platelets from 400 ml of freshly drawn blood were isolated, washed, frozen and homogenized as described in the Materials and methods section. Then 2 ml of a low-speedsupernatant fraction was layered on a 30 6000 -sorbitol gradient, centrifuged, and membrane fractions were collected as in Fig. 1 and 2.9 respectively (n = 2). In contrast, the adenylate cyclase specific activity is lower in the L fraction, so that the relative specific activity in L compared with MH is 0.50, which quantitatively confirms the depletion seen in Figs. I(a) and 3. Latency of adenylate cyclase One phenomenon that could explain the apparent lack of adenylate cyclase activity in the L fraction is the existence of permeability barriers in the form of sealed vesicles. The highly charged [32P]ATP substrate would then be unable to enter the sealed vesicle to reach the catalytic site of adenylate cyclase on its inside surface. In an attempt to break down permeability barriers, membranes were preincubated with various concentrations of the non-ionic detergent Lubrol PX before an assay of forskolin-stimulated adenylate cyclase activity. unpublished work). In the M and H fractions there was respectively no effect and a small decrease in activity.
Effect of pretreatment of intact platelets with adrenaline
To identify changes in the subcellular distribution of the a2-adrenergic receptor or G, after desensitization, we preincubated platelets prepared from freshly drawn blood with 100 /M-adrenaline for 3 h at room temperature, followed by washing and fractionation as described above. The gradient distributions of the a2-adrenergic receptor and Gi for such an experiment are shown in Fig.   5 . Adenylate cyclase activity was not measured. There is no difference in the a2-adrenergic receptor distribution between the control and adrenaline-treated platelets, nor is there a significant difference in the overall yield of this marker between the two gradients (1.81 versus 1.84 pmol). There is no significant difference in either the nucleotides [33] . In neutrophils [8] and liver membranes [9] guanine-nucleotide-binding activity is detected in is not seen for G. [35] . Thus the notion that there is [8] in neutrophils. We do not adrenaline pretreatment on subcellular dissee any specific localization of Gi in the platelet granule of a2 receptor and G; fraction (H) over and above the amount resulting from ml of blood was prepared and treated with contamination with plasma membranes. If 300% of the described in the Materials and methods pertussis-toxin substrate in the platelet were localized in ise-gradient separation of the total homogranules, there would be a significant discrepancy benaline-treated (U, *) and control (El Q) tween the distribution of pertussis-toxin substrate activity performed as described for Fig. 3. [3H]-and the fluorescence lectin label. Activation of platelets inding (a) and pertussis-toxin substrate with adrenaline does not alter the amount or distribution nre measured on membranes pelleted from of Gi (Fig. 5 ), but activation with thrombin does decrease pertussis-toxin substrate activity ( [36, 37] ; J. C. Ferraro, unpublished work), as was seen in neutrophils with chemotactic peptide [34] . However, the data in neutrophils are conflicting on both of these points, too [8, 34] .
The pertussis-toxin substrate method used here for detecting G, in platelet extracts has some limitations.
First, it cannot distinguish among the multiple substrates that are present in mammalian cells [38] [39] [40] . Platelets do not contain G., the predominant G-protein in brain. Gi2
is the major pertussis-toxin substrate in platelets, with
Gi3 being present in a much smaller amount [41, 42] . Thus our data primarily reflect the distribution of ai2-Second, free a subunits will not be detected, because they are not efficient substrates for pertussis toxin [38] . This does not confound our conclusions, because addition of fy subunit does not increase the labelling by pertussis toxin in either membrane extracts or cytosol fractions (Fig. 2) . Adenylate cyclase has generally been considered to be a plasma-membrane enzyme. By the free-flowelectrophoresis technique, this enzyme was found to predominate in the plasma-membrane fraction [30] , but the specific activities reported by that group were at least 50-fold lower than those typically seen in our laboratory, so this result is hard to reconcile with our findings. Using a histochemical technique, one group reported the localization of prostaglandin E1-stimulatable adenylate cyclase to the dense tubular system in human platelets [45, 46] . Our data suggest the existence of a pool of adenylate cyclase activity in an non-plasma-membrane fraction; however, the complex effects of Lubrol on the enzyme activity prevent us from definitively ruling out latency as the sole mechanism. More direct measures of the distribution of adenylate cyclase protein rather than activity will be necessary to clarify this issue. The degree of latency of adenylate cyclase in the lightmembrane/vesicle preparation suggests that at least twothirds of this fraction consists of sealed right-side-out vesicles. This property may prove useful in studies of the sidedness of various plasma membrane components.
In astrocytoma cells [22] and frog erythrocytes [23] , the distribution of fl-adrenergic receptors changes after prolonged treatment of the cells with agonist. Stadel et al. [23] reported a decrease in the number ofsurface receptors and the recovery of most of these 'lost' receptors in the form of intracellular vesicles containing neither G. or adenylate cyclase activity. Agonist binding and response data indicate that these receptors are 'uncoupled' from Gs. In contrast, desensitization of the a2-agonistmediated platelet-aggregation response [44] occurs distal to the regulation of adenylate cyclase. Our findings also indicate that uncoupling of the a2 receptors and Gi does not occur after agonist exposure in human platelets.
To explain the presence of low-affinity x2-agonist binding in the presence of excess Gi, we have proposed that either the receptor or Gi is heterogeneous, or that these two elements are 'compartmentalized' in the cell in such a way that not all of the Gi pool is capable of interacting with the receptor [15, 47] . The studies reported here were designed to test the compartmentation hypothesis. The co-migration of the ac2-adrenergic receptor and G, in density-gradient centrifugation points away from compartmentation in distinct subcellular fractions. If compartmentation is the mechanism, it would have to be at the level of lateral domains of the membrane, as recently reported for human neutrophils [48] or tight interactions of the Gi with other receptors or perhaps cytoskeletal elements ( [49] , and see above). The hypotheses of receptor heterogeneity and cytoskeletal interactions require investigation.
